Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

EFFICACY OF HEMOSPRAY AND ENDOCLOT IN THE TREATMENT OF GASTROINTESTINAL BLEEDING: RESULTS FROM A TERTIARY REFFERAL CENTER (2018) Vitali F, Naegel A, Neurath M, Rath T, Siebler J Conference contribution ENDOSCOPIC FULL-THICKNESS RESECTION IN THE COLORECTUM USING THE FTRD: RESULTS FROM A UNIVERSITY TERTIARY REFERRAL CENTER (2018) Vitali F, Naegel A, Neurath M, Rath T, Siebler J Conference contribution I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trial (2018) Klenske E, Zopf S, Neufert C, Naegel A, Gschossmann J, Muehldorfer S, Pfeifer L, et al. Journal article Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing (2018) Leppkes M, Siegmund B, Becker C Journal article, Editorial IFN-α in advanced well-differentiated neuroendocrine tumors: the neglected drug? (2018) Amoroso V, Pavel ME, Claps M, Roca E, Ravanelli M, Maroldi R, Oberg K, Berruti A Journal article Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension (2018) Pavel ME, Cwikla J, Wolin E, Phan A, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS (2018) Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Görtz R, Janka RM, et al. Journal article IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitis (2018) Zundler S, Spocinska M, Popp V, Becker E, Atreya R, Neufert C, Atreya I, et al. Conference contribution Final Progression-Free Survival Analyses for Lanreotide Autogel/Depot 120 mg in Metastatic Enteropancreatic Neuroendocrine Tumors: The CLARINET Extension Study (2018) Wolin EM, Pavel ME, Cwikla JB, Phan AT, Raderer M, Sedlackova E, Cadiot G, et al. Conference contribution Efficacy and Safety of Telotristat Ethyl in Patients With Carcinoid Syndrome Inadequately Controlled by Somatostatin Analogs: Analysis of the Completed TELESTAR Extension Period (2018) Hoersch D, Kulke MH, Caplin ME, Anthony LB, Bergsland E, Oberg K, Warner RRP, et al. Conference contribution